Literature DB >> 17878241

Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training.

Matthias Blüher1, Catherine J Williams, Nora Klöting, Alex Hsi, Karen Ruschke, Andreas Oberbach, Mathias Fasshauer, Janin Berndt, Michael R Schön, Alicja Wolk, Michael Stumvoll, Christos S Mantzoros.   

Abstract

OBJECTIVE: Adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2, respectively) mediate the effects of adiponectin on glucose and lipid metabolism in vivo. We examined whether AdipoR1 and/or AdipoR2 mRNA expression in human adipose tissue is fat-depot specific. We also studied whether their expression in visceral and subcutaneous fat depots is associated with metabolic parameters and whether their expression is regulated by intensive physical exercise. RESEARCH DESIGN AND METHODS: We determined metabolic parameters and assessed AdipoR1 and AdipoR2 mRNA expression using quantitative real-time PCR in adipose tissue in an observational study of 153 subjects and an interventional study of 60 subjects (20 each with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes) before and after intensive physical training for 4 weeks.
RESULTS: AdipoR1 and AdipoR2 mRNA expression is not significantly different between omental and subcutaneous fat, but their expression is several-fold lower in adipose tissue than in muscle. AdipoR2 mRNA expression in visceral fat is highly correlated with its expression in subcutaneous fat. AdipoR2 mRNA expression in both visceral and subcutaneous fat is positively associated with circulating adiponectin and HDL levels but negatively associated with obesity as well as parameters of insulin resistance, glycemia, and other lipid levels before and after adjustment for fat mass. Physical training for 4 weeks resulted in increased AdipoR1 and AdipoR2 mRNA expression in subcutaneous fat.
CONCLUSIONS: AdipoR2 mRNA expression in fat is negatively associated with insulin resistance and metabolic parameters independently of obesity and may mediate the improvement of insulin resistance in response to exercise.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878241      PMCID: PMC2732345          DOI: 10.2337/dc07-1257

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

1.  Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure.

Authors:  S Goya Wannamethee; Peter H Whincup; Lucy Lennon; Naveed Sattar
Journal:  Arch Intern Med       Date:  2007-07-23

Review 2.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.

Authors:  Anders H Berg; Terry P Combs; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2002-03       Impact factor: 12.015

3.  Expression of adiponectin receptors in pancreatic beta cells.

Authors:  Ilham Kharroubi; Joanne Rasschaert; Décio L Eizirik; Miriam Cnop
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

Review 4.  Adiponectin: systemic contributor to insulin sensitivity.

Authors:  Utpal B Pajvani; Philipp E Scherer
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

5.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

6.  Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes.

Authors:  Mathias Fasshauer; Johannes Klein; Susan Kralisch; Margit Klier; Ulrike Lössner; Matthias Blüher; Ralf Paschke
Journal:  FEBS Lett       Date:  2004-01-30       Impact factor: 4.124

Review 7.  Adiponectin: A novel adipokine linking adipocytes and vascular function.

Authors:  Barry J Goldstein; Rosario Scalia
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.

Authors:  Anna M Wolf; Dominik Wolf; Holger Rumpold; Barbara Enrich; Herbert Tilg
Journal:  Biochem Biophys Res Commun       Date:  2004-10-15       Impact factor: 3.575

9.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.

Authors:  Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Atsushi Tsuchida; Takehiko Yokomizo; Shunbun Kita; Takuya Sugiyama; Makoto Miyagishi; Kazuo Hara; Masaki Tsunoda; Koji Murakami; Toshiaki Ohteki; Shoko Uchida; Sato Takekawa; Hironori Waki; Nelson H Tsuno; Yoichi Shibata; Yasuo Terauchi; Philippe Froguel; Kazuyuki Tobe; Shigeo Koyasu; Kazunari Taira; Toshio Kitamura; Takao Shimizu; Ryozo Nagai; Takashi Kadowaki
Journal:  Nature       Date:  2003-06-12       Impact factor: 49.962

10.  Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity.

Authors:  Atsushi Tsuchida; Toshimasa Yamauchi; Yusuke Ito; Yusuke Hada; Toshiyuki Maki; Sato Takekawa; Junji Kamon; Masaki Kobayashi; Ryo Suzuki; Kazuo Hara; Naoto Kubota; Yasuo Terauchi; Philippe Froguel; Jun Nakae; Masato Kasuga; Domenico Accili; Kazuyuki Tobe; Kohjiro Ueki; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

View more
  31 in total

Review 1.  Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity.

Authors:  Chandra Kanti Chakraborti
Journal:  World J Diabetes       Date:  2015-11-10

Review 2.  Adipokines and insulin resistance.

Authors:  Katja Rabe; Michael Lehrke; Klaus G Parhofer; Uli C Broedl
Journal:  Mol Med       Date:  2008-09-17       Impact factor: 6.354

3.  Circadian expression of adiponectin and its receptors in human adipose tissue.

Authors:  P Gómez-Abellán; C Gómez-Santos; J A Madrid; F I Milagro; J Campion; J A Martínez; J M Ordovás; M Garaulet
Journal:  Endocrinology       Date:  2009-11-03       Impact factor: 4.736

4.  Metabolic adaptations in skeletal muscle, adipose tissue, and whole-body oxidative capacity in response to resistance training.

Authors:  Malin Alvehus; Niklas Boman; Karin Söderlund; Michael B Svensson; Jonas Burén
Journal:  Eur J Appl Physiol       Date:  2014-04-08       Impact factor: 3.078

Review 5.  Adiponectin: Probe of the molecular paradigm associating diabetes and obesity.

Authors:  Kakali Ghoshal; Maitree Bhattacharyya
Journal:  World J Diabetes       Date:  2015-02-15

Review 6.  Adiponectin in insulin resistance: lessons from translational research.

Authors:  Florencia Ziemke; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

7.  Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training.

Authors:  Karen Ruschke; Lauren Fishbein; Arne Dietrich; Nora Klöting; Anke Tönjes; Andreas Oberbach; Mathias Fasshauer; Jost Jenkner; Michael R Schön; Michael Stumvoll; Matthias Blüher; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2009-12-04       Impact factor: 6.664

8.  Exercise-induced Signals for Vascular Endothelial Adaptations: Implications for Cardiovascular Disease.

Authors:  Nathan T Jenkins; Jeffrey S Martin; M Harold Laughlin; Jaume Padilla
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-08-01

9.  Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes.

Authors:  Iosif Halvatsiotis; Panayoula C Tsiotra; Ignatios Ikonomidis; Anastasios Kollias; Panagiota Mitrou; Eirini Maratou; Eleni Boutati; John Lekakis; George Dimitriadis; Theofanis Economopoulos; Dimitrios T Kremastinos; Sotirios A Raptis
Journal:  Cardiovasc Diabetol       Date:  2010-02-23       Impact factor: 9.951

10.  Enhanced insulin sensitivity after acute exercise is not associated with changes in high-molecular weight adiponectin concentration in plasma.

Authors:  Faidon Magkos; B Selma Mohammed; Bettina Mittendorfer
Journal:  Eur J Endocrinol       Date:  2009-10-28       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.